Organizing Committee Members - Immuno Oncology 2022
Wassil Nowicky
Founder
Nowicky Pharma
Austria
Wassil Nowicky (Biography)
Wassil Nowicky is the Director of Nowicky Pharma and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). He has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) by the end of 1955 from graduation to Diplomingeniueur in 1960 whose title was nostrificated in Austria in 1975. He is the Author of over 300 scientific articles dedicated to cancer research. He is a real member of the New York Academy of Sciences, member of the European Union for Applied Immunology and of the American Association for scientific progress, Honorary Doctor of the Janka Kupala University in Hrodno, doctor honoris causa of the Open international university on Complex Medicine in Colombo, Honorary Member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmacists of America. the award of Austrian Society of sanitary, hygiene and publichealth services and others.
Wassil Nowicky (Research Area)
Oncology, Cancer, Immuno Oncology.
M G Hanna
Founder
Vaccinogen, Inc.
USA
M G Hanna (Biography)
Dr. Michael G. Hanna, Jr., Ph.D., founded Vaccinogen, Inc. in 2007 and served as its Chairman and Chief Executive Officer until August 2014. Dr. Hanna served as the Chief Scientific Officer of Vaccinogen, Inc., and served as its Chief Executive Officer until October 1st 2010. He served as the Chief Scientific Officer of Intracel Holdings Corporation. He served as the Chairman of the Board, Chief Executive Officer and President of PerImmune, Inc. He served as President of Intracel Holdings Corporation. From 1985 to 1994, he was the Chief Operating Officer of Organon Teknika/Biotechnology Research Institute. He founded the Litton Institute of Applied Biotechnology (LIAB), which Organon Teknika acquired in 1985 and was a Senior Vice President at Organon Teknika. Dr. Hanna served as the Chairman of Intracel Holdings Corporation. Dr. Hanna served as Chairman Emeritus at Vaccinogen, Inc. since August 2014 at Vaccinogen, Inc. and also served as its Director and Member of Medical Advisory Board until September 29, 2017. He served as a Director of the National Cancer Institute From 1975 to 1983, Frederick Cancer Research Center.
M G Hanna (Research Area)
Cancer, Immunology.
Weisi Yan
Director
CyberKnife Program, University of South Alabama
USA
Weisi Yan(Biography)
Dr. Yan finished his Ph.D. in pharmacology in Weill Graduate school of Cornell medical College. He was trained in NYP/Cornell for clinical radiation oncology. He subsequently held faculty appointments at New York-Presbyterian Hospital and New York Hospital Queens. He also served as an assistant professor of clinical radiology at the Weill Cornell Medical College of Cornell University. Dr. Yan's specialties are head and neck cancers, lung cancer, lymphoma and GI cancers. In addition, Yan has extensive training in Stereotactic Radiation Therapy, in which high-dose radiotherapy beams are aimed at a tumor from many different directions with a high level of precision. He is also the director of the CyberKnife Robotic Radiotherapy System at Mitchell cancer Institute at the University of South Alabama.
Weisi Yan(Research Area)
Head and Neck Cancers, Lung cancer, Lymphomaand GI cancers.
Donglu Shi
Professor
University of Cincinnati
USA
Donglu Shi (Biography)
Donglu Shi is currently the Chair of the Materials Science and Engineering Program at the University of Cincinnati. Donglu Shi received his Ph. D. in Engineering from the University of Massachusetts at Amherst. He was the Staff Scientist in the Materials Science Division of Argonne National Laboratory between 1988 and 1995. Donglu Shi has so far published 270 refereed SCI journal publications including Physical Review Letters, Nature, ACS Nano, and Advanced Materials. Donglu Shi’s main interests include nanostructure design, nano biomedicine, nanophotonics, and magnetism. The most recent works pioneer several novel approaches in developing multifunctional nano carrier systems for early cancer diagnosis and therapy.
Donglu Shi (Research Area)
Developing multifunctional nano carrier systems for early cancer diagnosis and therapy.
Reham Abdel-Wahab
Postdoctoral Fellow
University of Texas MD Anderson Cancer Center |
USA
Reham Abdel-Wahab(Biography)
Reham Abdelwahab Hassan Ali is a Postdoctoral Fellow in Gi Med Oncology - Research, a department of The University of Texas MD Anderson Cancer Center. She is also a lecturer and consultant physician of clinical oncology at Assiut University hospital. And she was also Assistant Lecturer at Assiut University.
Reham Abdel-Wahab(Research Area)
Cancer, Cancer Biology, Cancer Immunology.
Piyush Vyas
Consultant Clinical Oncologist
Warsaw Medical University Hospital
Poland
Piyush Vyas(Biography)
Doctor of Medicine (M.D.) Field Of StudySpecialisation -Clinical Oncology (Completed 2012-April) Activities and Societies: Full Member -European Society of Medical Oncology. Former Associate member -American Society of Clinical Oncology. Member -Polish Society of Clinical Oncology.
Piyush Vyas(Research Area)
Clinical Oncology.